Jade Biosciences, Inc. (JBIO)
16.57
+0.17
(+1.04%)
USD |
NASDAQ |
Nov 11, 16:00
16.57
0.00 (0.00%)
After-Hours: 17:23
Jade Biosciences Price to Book Value : 2.394 for Nov. 11, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 10, 2026 | 2.369 |
| November 09, 2026 | 2.254 |
| November 06, 2026 | 2.177 |
| November 05, 2026 | 2.037 |
| November 04, 2026 | 2.173 |
| November 03, 2026 | 2.105 |
| November 02, 2026 | 2.012 |
| October 30, 2026 | 2.031 |
| October 29, 2026 | 2.057 |
| October 28, 2026 | 2.108 |
| October 27, 2026 | 2.130 |
| October 26, 2026 | 2.095 |
| October 23, 2026 | 2.108 |
| October 22, 2026 | 2.154 |
| October 21, 2026 | 2.186 |
| October 20, 2026 | 2.147 |
| October 19, 2026 | 1.998 |
| October 16, 2026 | 1.946 |
| October 15, 2026 | 1.988 |
| October 14, 2026 | 1.942 |
| October 13, 2026 | 1.939 |
| October 12, 2026 | 2.023 |
| October 09, 2026 | 2.079 |
| October 08, 2026 | 2.044 |
| October 07, 2026 | 1.989 |
| Date | Value |
|---|---|
| October 06, 2026 | 1.937 |
| October 05, 2026 | 2.033 |
| October 02, 2026 | 2.04 |
| October 01, 2026 | 1.989 |
| September 30, 2026 | 2.030 |
| September 29, 2026 | 2.049 |
| September 28, 2026 | 2.073 |
| September 25, 2026 | 2.083 |
| September 24, 2026 | 2.128 |
| September 23, 2026 | 2.125 |
| September 22, 2026 | 2.421 |
| September 21, 2026 | 2.418 |
| September 18, 2026 | 2.447 |
| September 17, 2026 | 2.476 |
| September 16, 2026 | 2.406 |
| September 15, 2026 | 2.511 |
| September 14, 2026 | 2.626 |
| September 11, 2026 | 2.585 |
| September 10, 2026 | 2.765 |
| September 09, 2026 | 2.754 |
| September 08, 2026 | 2.81 |
| September 04, 2026 | 2.875 |
| September 03, 2026 | 2.868 |
| September 02, 2026 | 3.092 |
| September 01, 2026 | 3.037 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.286 |
| Alnylam Pharmaceuticals, Inc. | 5.936 |
| Anika Therapeutics, Inc. | 1.354 |
| Savara, Inc. | 9.472 |
| Vericel Corp. | 7.902 |
Price to Book Value Related Metrics
| Price | 16.57 |
| Earnings Yield | -15.77% |
| Market Cap | 1.053B |